| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | ANK2 IQGAP2 CENPE DISC1 CEP290 CEP57L1 NEB LCP1 EPB41L3 LMOD3 SMC3 CGN CEP135 CEP70 CDK5RAP2 KIF3C KIF5A DIAPH3 PLEC FMNL1 KLC1 NIN | 1.79e-06 | 1099 | 128 | 22 | GO:0008092 |
| GeneOntologyMolecularFunction | tubulin binding | CENPE CEP290 CEP57L1 SMC3 CGN CEP135 CEP70 CDK5RAP2 KIF3C KIF5A DIAPH3 KLC1 NIN | 3.82e-06 | 428 | 128 | 13 | GO:0015631 |
| GeneOntologyMolecularFunction | microtubule motor activity | 5.78e-06 | 70 | 128 | 6 | GO:0003777 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.10e-05 | 118 | 128 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | microtubule binding | CENPE CEP290 CEP57L1 CGN CEP135 CDK5RAP2 KIF3C KIF5A DIAPH3 NIN | 3.00e-05 | 308 | 128 | 10 | GO:0008017 |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 5.71e-05 | 33 | 128 | 4 | GO:0005217 | |
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 1.22e-04 | 3 | 128 | 2 | GO:0005220 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DNAH3 CFTR CLPX DDX46 SMC3 KIF3C DDX43 KIF5A ASCC3 DHX29 ALPL | 1.29e-04 | 441 | 128 | 11 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | DNHD1 DNAH3 CENPE CFTR CLPX DDX46 SMC3 KIF3C DDX43 KIF5A ASCC3 DHX29 ALPL | 1.61e-04 | 614 | 128 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.96e-04 | 18 | 128 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | mediator complex binding | 2.43e-04 | 4 | 128 | 2 | GO:0036033 | |
| GeneOntologyMolecularFunction | kinesin binding | 4.27e-04 | 55 | 128 | 4 | GO:0019894 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.01e-03 | 31 | 128 | 3 | GO:0099604 | |
| GeneOntologyBiologicalProcess | microtubule-based process | CCNL2 DNHD1 DNAH3 CENPE DISC1 PPP1R12A CEP290 SPECC1L CCDC39 SMC3 CGN CEP135 CEP70 CDK5RAP2 KIF3C KIF5A DIAPH3 PARD3 CFAP53 KLC1 NIN | 2.49e-06 | 1058 | 129 | 21 | GO:0007017 |
| GeneOntologyBiologicalProcess | organelle assembly | DNHD1 CENPE CEP162 DISC1 CEP290 NEB LCP1 CCDC39 CEP164 ASAP1 CC2D2B LMOD3 TBC1D31 SMC3 CEP135 CEP70 CDK5RAP2 DIAPH3 PLEC DHX29 CFAP53 | 7.70e-06 | 1138 | 129 | 21 | GO:0070925 |
| GeneOntologyBiologicalProcess | cortical actin cytoskeleton organization | 8.85e-06 | 45 | 129 | 5 | GO:0030866 | |
| GeneOntologyBiologicalProcess | cilium assembly | DNHD1 CEP162 DISC1 CEP290 CCDC39 CEP164 ASAP1 CC2D2B TBC1D31 CEP135 CEP70 CFAP53 | 2.30e-05 | 444 | 129 | 12 | GO:0060271 |
| GeneOntologyBiologicalProcess | cortical cytoskeleton organization | 2.86e-05 | 57 | 129 | 5 | GO:0030865 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | CCNL2 CENPE DISC1 PPP1R12A CEP290 SPECC1L CCDC39 SMC3 CGN CEP135 CEP70 CDK5RAP2 DIAPH3 PARD3 NIN | 4.50e-05 | 720 | 129 | 15 | GO:0000226 |
| GeneOntologyBiologicalProcess | cilium organization | DNHD1 CEP162 DISC1 CEP290 CCDC39 CEP164 ASAP1 CC2D2B TBC1D31 CEP135 CEP70 CFAP53 | 4.53e-05 | 476 | 129 | 12 | GO:0044782 |
| GeneOntologyCellularComponent | microtubule organizing center | CEP162 DISC1 PPP1R12A CEP290 CEP57L1 SPECC1L DPF2 TEX9 CEP164 LUZP1 TBC1D31 PLEKHG6 GLE1 STEEP1 CEP135 CEP70 CDK5RAP2 DIAPH3 PLEKHA7 CFAP53 NIN | 1.57e-07 | 919 | 127 | 21 | GO:0005815 |
| GeneOntologyCellularComponent | centrosome | CEP162 DISC1 PPP1R12A CEP290 CEP57L1 DPF2 TEX9 CEP164 LUZP1 TBC1D31 PLEKHG6 GLE1 STEEP1 CEP135 CEP70 CDK5RAP2 PLEKHA7 CFAP53 NIN | 2.05e-07 | 770 | 127 | 19 | GO:0005813 |
| GeneOntologyCellularComponent | cilium | DNHD1 DNAH3 TCP11X1 TCP11X2 CEP162 DISC1 CEP290 RIBC1 CCDC39 CEP164 CC2D2B TBC1D31 GLE1 KIF3C KIF5A USP48 CFAP53 KLC1 NIN | 2.06e-06 | 898 | 127 | 19 | GO:0005929 |
| GeneOntologyCellularComponent | supramolecular fiber | DNAH3 ANK2 IQGAP2 CENPE DSP CEP162 DISC1 PPP1R12A CEP57L1 RIBC1 SPECC1L NEB LCP1 LMOD3 CDK5RAP2 KIF3C KIF5A DIAPH3 PLEC CFAP53 KLC1 NIN | 2.34e-06 | 1179 | 127 | 22 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | DNAH3 ANK2 IQGAP2 CENPE DSP CEP162 DISC1 PPP1R12A CEP57L1 RIBC1 SPECC1L NEB LCP1 LMOD3 CDK5RAP2 KIF3C KIF5A DIAPH3 PLEC CFAP53 KLC1 NIN | 2.61e-06 | 1187 | 127 | 22 | GO:0099081 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | DNAH3 IQGAP2 CENPE DSP CEP162 DISC1 CEP57L1 RIBC1 SPECC1L LCP1 CDK5RAP2 KIF3C KIF5A DIAPH3 PLEC CFAP53 KLC1 NIN | 8.40e-06 | 899 | 127 | 18 | GO:0099513 |
| GeneOntologyCellularComponent | microtubule | DNAH3 IQGAP2 CENPE CEP162 DISC1 CEP57L1 RIBC1 CDK5RAP2 KIF3C KIF5A CFAP53 KLC1 NIN | 2.24e-05 | 533 | 127 | 13 | GO:0005874 |
| GeneOntologyCellularComponent | centriole | 8.82e-05 | 172 | 127 | 7 | GO:0005814 | |
| GeneOntologyCellularComponent | spindle | CENPE CEP162 SPECC1L PLEKHG6 SMC3 CDK5RAP2 DIAPH3 PARD3 ANAPC5 CFAP53 NIN | 1.44e-04 | 471 | 127 | 11 | GO:0005819 |
| GeneOntologyCellularComponent | kinesin complex | 2.23e-04 | 49 | 127 | 4 | GO:0005871 | |
| GeneOntologyCellularComponent | microtubule associated complex | 4.56e-04 | 161 | 127 | 6 | GO:0005875 | |
| GeneOntologyCellularComponent | platelet dense granule membrane | 5.41e-04 | 6 | 127 | 2 | GO:0031088 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 6.38e-04 | 238 | 127 | 7 | GO:0097729 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 7.20e-04 | 317 | 127 | 8 | GO:0032838 | |
| GeneOntologyCellularComponent | central region of growth cone | 7.54e-04 | 7 | 127 | 2 | GO:0090724 | |
| GeneOntologyCellularComponent | centriolar satellite | 1.11e-03 | 128 | 127 | 5 | GO:0034451 | |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 1.28e-03 | 9 | 127 | 2 | GO:0031095 | |
| GeneOntologyCellularComponent | ciliary transition fiber | 1.60e-03 | 10 | 127 | 2 | GO:0097539 | |
| GeneOntologyCellularComponent | inner dynein arm | 1.60e-03 | 10 | 127 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | spindle pole | 1.60e-03 | 205 | 127 | 6 | GO:0000922 | |
| GeneOntologyCellularComponent | cytoplasmic region | 1.62e-03 | 360 | 127 | 8 | GO:0099568 | |
| GeneOntologyCellularComponent | axoneme | 1.68e-03 | 207 | 127 | 6 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 1.72e-03 | 208 | 127 | 6 | GO:0097014 | |
| GeneOntologyCellularComponent | platelet dense tubular network | 1.94e-03 | 11 | 127 | 2 | GO:0031094 | |
| GeneOntologyCellularComponent | mitotic spindle pole | 2.26e-03 | 43 | 127 | 3 | GO:0097431 | |
| GeneOntologyCellularComponent | actin cytoskeleton | FLT1 IQGAP2 PPP1R12A SPECC1L NEB LCP1 ASAP1 LMOD3 CGN DIAPH3 | 2.74e-03 | 576 | 127 | 10 | GO:0015629 |
| HumanPheno | Subglottic stenosis | 1.51e-05 | 17 | 48 | 4 | HP:0001607 | |
| Domain | Prefoldin | 1.12e-04 | 72 | 123 | 5 | IPR009053 | |
| Domain | InsP3_rcpt-bd | 1.29e-04 | 3 | 123 | 2 | IPR000493 | |
| Domain | TEX28/TMCC | 2.56e-04 | 4 | 123 | 2 | IPR019394 | |
| Domain | Tmemb_cc2 | 2.56e-04 | 4 | 123 | 2 | PF10267 | |
| Domain | WW_DOMAIN_1 | 3.52e-04 | 51 | 123 | 4 | PS01159 | |
| Domain | WW_DOMAIN_2 | 3.52e-04 | 51 | 123 | 4 | PS50020 | |
| Domain | WW_dom | 3.80e-04 | 52 | 123 | 4 | IPR001202 | |
| Domain | RIH_assoc-dom | 6.34e-04 | 6 | 123 | 2 | IPR013662 | |
| Domain | - | 6.34e-04 | 6 | 123 | 2 | 3.90.1290.10 | |
| Domain | Ins145_P3_rec | 6.34e-04 | 6 | 123 | 2 | PF08709 | |
| Domain | RIH_assoc | 6.34e-04 | 6 | 123 | 2 | PF08454 | |
| Domain | RIH_dom | 6.34e-04 | 6 | 123 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 6.34e-04 | 6 | 123 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 6.34e-04 | 6 | 123 | 2 | IPR015925 | |
| Domain | - | 6.34e-04 | 6 | 123 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 6.34e-04 | 6 | 123 | 2 | PF01365 | |
| Domain | Plectin | 8.84e-04 | 7 | 123 | 2 | PF00681 | |
| Domain | Plectin_repeat | 8.84e-04 | 7 | 123 | 2 | IPR001101 | |
| Domain | PLEC | 8.84e-04 | 7 | 123 | 2 | SM00250 | |
| Domain | CH | 8.89e-04 | 65 | 123 | 4 | SM00033 | |
| Domain | DAD_dom | 1.17e-03 | 8 | 123 | 2 | IPR014767 | |
| Domain | DAD | 1.17e-03 | 8 | 123 | 2 | PS51231 | |
| Domain | CH | 1.17e-03 | 70 | 123 | 4 | PF00307 | |
| Domain | - | 1.24e-03 | 71 | 123 | 4 | 1.10.418.10 | |
| Domain | DEAD/DEAH_box_helicase_dom | 1.37e-03 | 73 | 123 | 4 | IPR011545 | |
| Domain | CH | 1.37e-03 | 73 | 123 | 4 | PS50021 | |
| Domain | DEAD | 1.37e-03 | 73 | 123 | 4 | PF00270 | |
| Domain | Drf_GBD | 1.50e-03 | 9 | 123 | 2 | PF06371 | |
| Domain | Drf_FH3 | 1.50e-03 | 9 | 123 | 2 | PF06367 | |
| Domain | FH3_dom | 1.50e-03 | 9 | 123 | 2 | IPR010472 | |
| Domain | GTPase-bd | 1.50e-03 | 9 | 123 | 2 | IPR010473 | |
| Domain | Drf_FH3 | 1.50e-03 | 9 | 123 | 2 | SM01139 | |
| Domain | Drf_GBD | 1.50e-03 | 9 | 123 | 2 | SM01140 | |
| Domain | CH-domain | 1.52e-03 | 75 | 123 | 4 | IPR001715 | |
| Domain | MIR | 1.87e-03 | 10 | 123 | 2 | PF02815 | |
| Domain | MIR_motif | 1.87e-03 | 10 | 123 | 2 | IPR016093 | |
| Domain | MIR | 1.87e-03 | 10 | 123 | 2 | PS50919 | |
| Domain | MIR | 1.87e-03 | 10 | 123 | 2 | SM00472 | |
| Domain | GBD/FH3_dom | 2.28e-03 | 11 | 123 | 2 | IPR014768 | |
| Domain | GBD_FH3 | 2.28e-03 | 11 | 123 | 2 | PS51232 | |
| Domain | Kinesin_motor_CS | 2.48e-03 | 41 | 123 | 3 | IPR019821 | |
| Domain | Kinesin-like_fam | 2.84e-03 | 43 | 123 | 3 | IPR027640 | |
| Domain | Ank_2 | 3.02e-03 | 215 | 123 | 6 | PF12796 | |
| Domain | - | 3.03e-03 | 44 | 123 | 3 | 3.40.850.10 | |
| Domain | Kinesin | 3.03e-03 | 44 | 123 | 3 | PF00225 | |
| Domain | KISc | 3.03e-03 | 44 | 123 | 3 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 3.03e-03 | 44 | 123 | 3 | PS00411 | |
| Domain | Kinesin_motor_dom | 3.03e-03 | 44 | 123 | 3 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 3.03e-03 | 44 | 123 | 3 | PS50067 | |
| Domain | RasGAP | 3.72e-03 | 14 | 123 | 2 | SM00323 | |
| Domain | Dynein_HC_stalk | 3.72e-03 | 14 | 123 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 3.72e-03 | 14 | 123 | 2 | IPR013602 | |
| Domain | DHC_N2 | 3.72e-03 | 14 | 123 | 2 | PF08393 | |
| Domain | MT | 3.72e-03 | 14 | 123 | 2 | PF12777 | |
| Domain | RasGAP_CS | 3.72e-03 | 14 | 123 | 2 | IPR023152 | |
| Domain | WW | 3.88e-03 | 48 | 123 | 3 | SM00456 | |
| Domain | P-loop_NTPase | DNHD1 DNAH3 CENPE CFTR CLPX DDX46 SMC3 CARD11 KIF3C DDX43 KIF5A ASCC3 DHX29 | 3.90e-03 | 848 | 123 | 13 | IPR027417 |
| Domain | Ank | 4.03e-03 | 228 | 123 | 6 | PF00023 | |
| Domain | DHC_fam | 4.27e-03 | 15 | 123 | 2 | IPR026983 | |
| Domain | RasGAP | 4.27e-03 | 15 | 123 | 2 | PF00616 | |
| Domain | RAS_GTPASE_ACTIV_1 | 4.27e-03 | 15 | 123 | 2 | PS00509 | |
| Domain | FH2 | 4.27e-03 | 15 | 123 | 2 | PS51444 | |
| Domain | Dynein_heavy | 4.27e-03 | 15 | 123 | 2 | PF03028 | |
| Domain | FH2_Formin | 4.27e-03 | 15 | 123 | 2 | IPR015425 | |
| Domain | FH2 | 4.27e-03 | 15 | 123 | 2 | PF02181 | |
| Domain | RAS_GTPASE_ACTIV_2 | 4.27e-03 | 15 | 123 | 2 | PS50018 | |
| Domain | Dynein_heavy_dom | 4.27e-03 | 15 | 123 | 2 | IPR004273 | |
| Domain | FH2 | 4.27e-03 | 15 | 123 | 2 | SM00498 | |
| Domain | - | 4.86e-03 | 16 | 123 | 2 | 1.10.506.10 | |
| Domain | Helicase_C | 5.49e-03 | 107 | 123 | 4 | PF00271 | |
| Domain | HELICc | 5.49e-03 | 107 | 123 | 4 | SM00490 | |
| Domain | Helicase_C | 5.67e-03 | 108 | 123 | 4 | IPR001650 | |
| Domain | HELICASE_CTER | 5.86e-03 | 109 | 123 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 5.86e-03 | 109 | 123 | 4 | PS51192 | |
| Domain | DEXDc | 5.86e-03 | 109 | 123 | 4 | SM00487 | |
| Domain | - | 6.03e-03 | 248 | 123 | 6 | 1.25.40.20 | |
| Domain | Helicase_ATP-bd | 6.05e-03 | 110 | 123 | 4 | IPR014001 | |
| Domain | RasGAP_dom | 6.14e-03 | 18 | 123 | 2 | IPR001936 | |
| Domain | ANK | 6.38e-03 | 251 | 123 | 6 | SM00248 | |
| Pathway | REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE | 1.41e-05 | 217 | 94 | 9 | MM14708 | |
| Pathway | REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION | 2.14e-05 | 85 | 94 | 6 | MM14906 | |
| Pathway | REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION | 2.45e-05 | 87 | 94 | 6 | M27194 | |
| Pathway | REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE | 4.28e-05 | 96 | 94 | 6 | MM15207 | |
| Pathway | REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE | 4.54e-05 | 97 | 94 | 6 | M27478 | |
| Pathway | REACTOME_CILIUM_ASSEMBLY | 5.80e-05 | 201 | 94 | 8 | M27472 | |
| Pathway | REACTOME_AURKA_ACTIVATION_BY_TPX2 | 1.09e-04 | 71 | 94 | 5 | MM15495 | |
| Pathway | REACTOME_AURKA_ACTIVATION_BY_TPX2 | 1.16e-04 | 72 | 94 | 5 | M27749 | |
| Pathway | REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE | 1.61e-04 | 297 | 94 | 9 | M27050 | |
| Pathway | REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES | 2.03e-04 | 81 | 94 | 5 | M748 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 3.15e-04 | 257 | 94 | 8 | MM14755 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 3.33e-04 | 90 | 94 | 5 | MM14979 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 3.99e-04 | 202 | 94 | 7 | MM15362 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 4.24e-04 | 204 | 94 | 7 | M4217 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 4.28e-04 | 95 | 94 | 5 | M6729 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY | 4.34e-04 | 5 | 94 | 2 | M49000 | |
| Pathway | REACTOME_KINESINS | 5.59e-04 | 57 | 94 | 4 | MM15714 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY | 6.48e-04 | 6 | 94 | 2 | M47960 | |
| Pathway | REACTOME_KINESINS | 7.24e-04 | 61 | 94 | 4 | M977 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 1.06e-03 | 116 | 94 | 5 | MM15715 | |
| Pathway | REACTOME_M_PHASE | 1.10e-03 | 387 | 94 | 9 | MM15364 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | MIA3 ACACB CENPE DSP CEP162 CEP290 RIBC1 CCDC50 TEX9 LCP1 CEP164 LUZP1 ASAP1 PPP1R7 RBSN EIF2D TBC1D31 CGN CEP135 PLEC PLEKHA7 KLC1 NIN | 1.17e-13 | 853 | 130 | 23 | 28718761 |
| Pubmed | MIA3 ACACB CEP162 GIGYF1 DPF2 EPB41L3 LUZP1 STK4 SMC3 CGN AMOTL2 PARD3 PLEKHA7 ANAPC5 FMNL1 NIN | 1.31e-11 | 446 | 130 | 16 | 24255178 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | FLT1 ACACB CENPE PPP1R12A FNBP4 MRPS27 NEB LCP1 EPB41L3 RTF1 DDX46 GTF3C1 SMC3 SCN9A ASCC3 | 6.45e-10 | 497 | 130 | 15 | 36774506 |
| Pubmed | ANK2 ACACB IQGAP2 PCDHGB6 DSP PPP1R12A CCDC50 NCBP1 FAM98B CLPX NEB LCP1 EPB41L3 LUZP1 LMOD3 TBC1D31 GTF3C1 SCN9A KIF5A DIAPH3 PLEC NIPBL OBI1 GOLGB1 | 7.37e-10 | 1442 | 130 | 24 | 35575683 | |
| Pubmed | Cep120 and TACCs control interkinetic nuclear migration and the neural progenitor pool. | 8.48e-10 | 13 | 130 | 5 | 17920017 | |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | PPP1R12A FNBP4 NCBP1 SPECC1L FAM98B LCP1 ITPR1 ITPR2 MED15 STK4 EIF2D SMC3 STEEP1 PLEC ASCC3 FMNL1 LRRFIP2 | 1.21e-09 | 701 | 130 | 17 | 30196744 |
| Pubmed | DSP PPP1R12A FNBP4 SPECC1L LUZP1 MED15 DDX46 GTF3C1 CGN STEEP1 DIAPH3 AMOTL2 ASCC3 PARD3 KLC1 | 2.49e-09 | 549 | 130 | 15 | 38280479 | |
| Pubmed | MIA3 ANK2 IQGAP2 CENPE PPP1R12A SPECC1L EPB41L3 LUZP1 PPP1R7 MORF4L1 CDK5RAP2 PLCL1 KIF5A PARD3 NIPBL GOLGB1 KLC1 LRRFIP2 | 2.18e-08 | 963 | 130 | 18 | 28671696 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DSP CEP162 PPP1R12A LAMC1 GIGYF1 EPB41L3 TMCC3 LUZP1 STK4 RBSN CGN PLEC PARD3 PLEKHA7 OBI1 GOLGB1 KLC1 | 2.52e-08 | 861 | 130 | 17 | 36931259 |
| Pubmed | FRAS1 MIA3 ANK2 FNBP4 MRPS27 LAMC1 CLPX EPB41L3 TMCC3 ITPR1 ITPR2 TBC1D31 ROBO1 CDK5RAP2 DIAPH3 ASCC3 PARD3 USP48 DHX29 GOLGB1 KLC1 NIN | 3.40e-08 | 1487 | 130 | 22 | 33957083 | |
| Pubmed | DSP CEP290 SPECC1L NEB EPB41L3 CBLB ASAP1 SMC3 ROBO1 KIF5A PLEC OBI1 GOLGB1 | 3.92e-08 | 486 | 130 | 13 | 20936779 | |
| Pubmed | Proteomic characterization of the human centrosome by protein correlation profiling. | 4.17e-08 | 26 | 130 | 5 | 14654843 | |
| Pubmed | ACACB DSP LAMC1 EPB41L3 LUZP1 GTF3C1 DIAPH3 PLEC ASCC3 OBI1 GOLGB1 KLC1 | 6.25e-08 | 418 | 130 | 12 | 34709266 | |
| Pubmed | MIA3 DSP CEP162 CEP290 NCBP1 CLPX LUZP1 ASAP1 ITPR1 ITPR2 PPP1R7 TBC1D31 CGN CEP135 ROBO1 CDK5RAP2 PLEKHA7 NIN | 7.87e-08 | 1049 | 130 | 18 | 27880917 | |
| Pubmed | 8.38e-08 | 146 | 130 | 8 | 21399614 | ||
| Pubmed | CEP162 PPP1R12A CEP290 NCBP1 DPF2 LCP1 EPB41L3 LUZP1 MED15 TBC1D31 CEP135 KIF5A USP48 NIN | 1.50e-07 | 645 | 130 | 14 | 25281560 | |
| Pubmed | 2.04e-07 | 4 | 130 | 3 | 10828023 | ||
| Pubmed | 2.63e-07 | 234 | 130 | 9 | 36243803 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | DSP VPS33A NCBP1 EPB41L3 EIF2D DDX46 SMC3 MORF4L1 DIAPH3 PLEC USP48 NIPBL GOLGB1 | 3.10e-07 | 582 | 130 | 13 | 20467437 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | IQGAP2 DSP CEP162 PPP1R12A FAM98B CLPX EPB41L3 RTF1 PPP1R7 EIF2D SMC3 MORF4L1 CGN STEEP1 CEP135 PARD3 OBI1 KLC1 SOD2 | 3.25e-07 | 1284 | 130 | 19 | 17353931 |
| Pubmed | MIA3 CENPE CEP290 AGPAT3 PARP14 LUZP1 ITPR1 ITPR2 MED15 GTF3C1 GLE1 CD81 KIF5A ASCC3 FMNL1 HECA GOLGB1 KLC1 | 3.81e-07 | 1168 | 130 | 18 | 19946888 | |
| Pubmed | 4.74e-07 | 251 | 130 | 9 | 29778605 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | DNAH3 CENPE DSP DISC1 CEP290 NCBP1 PARP14 CCDC39 ITPR2 PPP1R7 GTF3C1 ANKRD18A AMOTL2 LRRFIP2 | 7.29e-07 | 736 | 130 | 14 | 29676528 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | ANPEP CENPE PPP1R12A DPF2 CLPX ITPR1 STK4 PPP1R7 DDX46 GTF3C1 SMC3 CEP135 CDK5RAP2 ANAPC5 NIPBL OBI1 LRRFIP2 | 1.55e-06 | 1155 | 130 | 17 | 20360068 |
| Pubmed | 1.71e-06 | 151 | 130 | 7 | 17043677 | ||
| Pubmed | The centrosomal protein C-Nap1 is required for cell cycle-regulated centrosome cohesion. | 2.21e-06 | 56 | 130 | 5 | 11076968 | |
| Pubmed | The PITSLRE/CDK11p58 protein kinase promotes centrosome maturation and bipolar spindle formation. | 2.42e-06 | 57 | 130 | 5 | 16462731 | |
| Pubmed | Polo-like kinase 1 regulates Nlp, a centrosome protein involved in microtubule nucleation. | 2.64e-06 | 58 | 130 | 5 | 12852856 | |
| Pubmed | ACACB PPP1R12A CEP57L1 SPECC1L DPF2 PLIN2 ITPR1 ITPR2 MORF4L1 PLEC ASCC3 | 3.21e-06 | 503 | 130 | 11 | 36217030 | |
| Pubmed | 3.40e-06 | 61 | 130 | 5 | 7790358 | ||
| Pubmed | 5.03e-06 | 66 | 130 | 5 | 12221128 | ||
| Pubmed | ANK2 IQGAP2 DSP PPP1R12A SPECC1L FAM98B EPB41L3 LUZP1 ASAP1 ITPR2 STK4 PPP1R7 PLCL1 PLEC PLEKHA7 DHX29 KLC1 LRRFIP2 | 6.65e-06 | 1431 | 130 | 18 | 37142655 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | DSP CEP290 LAMC1 NCBP1 SPECC1L ITPR2 DDX46 GTF3C1 SMC3 GLE1 CGN PLEC ASCC3 NIPBL GOLGB1 | 7.07e-06 | 1024 | 130 | 15 | 24711643 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | IQGAP2 PPP1R12A CEP290 AGPAT3 GIGYF1 LUZP1 MED15 STK4 PPP1R7 SMC3 SCML1 CGN KIF3C PLEC PARD3 PLEKHA7 KLC1 | 9.14e-06 | 1321 | 130 | 17 | 27173435 |
| Pubmed | 9.50e-06 | 274 | 130 | 8 | 34244482 | ||
| Pubmed | 1.04e-05 | 131 | 130 | 6 | 28634551 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RASA3 DSP DPF2 CLPX EPB41L3 LUZP1 ASAP1 STK4 EIF2D GTF3C1 SMC3 DDX43 PLEC ASCC3 PARD3 DHX29 NIPBL | 1.25e-05 | 1353 | 130 | 17 | 29467282 |
| Pubmed | CCNL2 ANK2 CENPE DSP FNBP4 LAMC1 NCBP1 SPECC1L PLIN2 ITPR1 CGN KLHL8 ASCC3 PLEKHA7 NIPBL ALPL | 1.29e-05 | 1215 | 130 | 16 | 15146197 | |
| Pubmed | MIA3 IQGAP2 CEP162 PPP1R12A CEP57L1 CCDC50 GOLM1 ASAP1 ITPR1 TBC1D31 CDK5RAP2 PLEC PARD3 PLEKHA7 GOLGB1 | 1.38e-05 | 1084 | 130 | 15 | 11544199 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 34465884 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 15201137 | ||
| Pubmed | Cholinergic augmentation of insulin release requires ankyrin-B. | 1.39e-05 | 2 | 130 | 2 | 20234002 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 14722080 | ||
| Pubmed | Sulphide signalling potentiates apoptosis through the up-regulation of IP3 receptor types 1 and 2. | 1.39e-05 | 2 | 130 | 2 | 23582047 | |
| Pubmed | Type 1 and 2 IP3 receptors respond differently to catecholamines and stress. | 1.39e-05 | 2 | 130 | 2 | 19120126 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 18708078 | ||
| Pubmed | Frcp1 and Frcp2, two novel fibronectin type III repeat containing genes. | 1.39e-05 | 2 | 130 | 2 | 12384288 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 18303017 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 35521900 | ||
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 1.40e-05 | 208 | 130 | 7 | 33230847 | |
| Pubmed | ANK2 IQGAP2 DSP FNBP4 MRPS27 LAMC1 NCBP1 SPECC1L FAM98B CLPX LUZP1 DDX46 CGN PLEC ASCC3 PARD3 LRRFIP2 | 1.48e-05 | 1371 | 130 | 17 | 36244648 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | DNAH3 MIA3 DSP VPS33A LAMC1 FAM98B LCP1 SMC3 KIF5A PLEC DHX29 NIPBL GOLGB1 | 1.85e-05 | 847 | 130 | 13 | 35235311 |
| Pubmed | 1.87e-05 | 497 | 130 | 10 | 23414517 | ||
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 1.96e-05 | 219 | 130 | 7 | 31353912 | |
| Pubmed | MIA3 CENPE CEP290 CCDC50 TEX9 PRPF18 ITPR2 STK4 TBC1D31 GLE1 CEP135 ROBO1 | 2.10e-05 | 733 | 130 | 12 | 34672954 | |
| Pubmed | C2cd3 is critical for centriolar distal appendage assembly and ciliary vesicle docking in mammals. | 2.25e-05 | 15 | 130 | 3 | 24469809 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | IQGAP2 DSP PPP1R12A MRPS27 FAM98B LCP1 LUZP1 PPP1R7 DDX46 GTF3C1 SMC3 PLEC ASCC3 OBI1 KLC1 | 2.71e-05 | 1149 | 130 | 15 | 35446349 |
| Pubmed | 2.76e-05 | 16 | 130 | 3 | 20301772 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | DNHD1 ANPEP IQGAP2 DSP LAMC1 NEB LCP1 PPP1R7 CDK5RAP2 CD81 PLEKHA7 CCDC180 NIPBL ALPL | 2.85e-05 | 1016 | 130 | 14 | 19056867 |
| Pubmed | CCNL2 CCDC50 CLPX RTF1 RBSN EIF2D DDX46 SMC3 STEEP1 CEP135 DIAPH3 METTL16 NIPBL OBI1 HECA SOD2 | 3.76e-05 | 1327 | 130 | 16 | 32694731 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | CCNL2 PPP1R12A CBLB LUZP1 ITPR2 RTF1 STK4 GTF3C1 CDK5RAP2 DDX43 PLEC ANAPC5 KLC1 | 3.87e-05 | 910 | 130 | 13 | 36736316 |
| Pubmed | Hemidesmosome integrity protects the colon against colitis and colorectal cancer. | 4.00e-05 | 18 | 130 | 3 | 27371534 | |
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 10874040 | ||
| Pubmed | Ankyrin-B metabolic syndrome combines age-dependent adiposity with pancreatic β cell insufficiency. | 4.15e-05 | 3 | 130 | 2 | 26168218 | |
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 20395455 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 17437169 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 20358602 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 18547250 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 36350267 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 32320395 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 11413485 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 26009177 | ||
| Pubmed | Clinical and genetic study of 20 patients from China with Cornelia de Lange syndrome. | 4.15e-05 | 3 | 130 | 2 | 29452578 | |
| Pubmed | Receptor-activated single channels in intact human platelets. | 4.15e-05 | 3 | 130 | 2 | 1693919 | |
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 23955339 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 31979185 | ||
| Pubmed | Tsg101 regulates PI(4,5)P2/Ca(2+) signaling for HIV-1 Gag assembly. | 4.15e-05 | 3 | 130 | 2 | 24904548 | |
| Pubmed | Disrupted-in-schizophrenia 1 regulates transport of ITPR1 mRNA for synaptic plasticity. | 4.15e-05 | 3 | 130 | 2 | 25821909 | |
| Pubmed | Differential distribution of inositol trisphosphate receptor isoforms in mouse oocytes. | 4.15e-05 | 3 | 130 | 2 | 9858485 | |
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 9808793 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 18194433 | ||
| Pubmed | IP3 receptors regulate vascular smooth muscle contractility and hypertension. | 4.15e-05 | 3 | 130 | 2 | 27777977 | |
| Pubmed | Differential inositol 1,4,5-trisphosphate receptor signaling in a neuronal cell line. | 4.15e-05 | 3 | 130 | 2 | 17581770 | |
| Pubmed | Congenital heart disease in Cornelia de Lange syndrome: phenotype and genotype analysis. | 4.15e-05 | 3 | 130 | 2 | 22965847 | |
| Pubmed | Predominant role of type 1 IP3 receptor in aortic vascular muscle contraction. | 4.15e-05 | 3 | 130 | 2 | 18241669 | |
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 19068129 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 17327232 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 23223241 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 16014380 | ||
| Pubmed | Mechanistic differences in actin bundling activity of two mammalian formins, FRL1 and mDia2. | 4.15e-05 | 3 | 130 | 2 | 16556604 | |
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 17890015 | ||
| Pubmed | Inositol 1, 4, 5-trisphosphate receptors and human left ventricular myocytes. | 4.15e-05 | 3 | 130 | 2 | 23983250 | |
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 20427533 | ||
| Pubmed | The filamentous actin cross-linking/bundling activity of mammalian formins. | 4.15e-05 | 3 | 130 | 2 | 18835565 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ANK2 ACACB DSP PPP1R12A CCDC50 EPB41L3 STK4 DDX46 STEEP1 DHX29 NIPBL GOLGB1 KLC1 | 5.04e-05 | 934 | 130 | 13 | 33916271 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 5.28e-05 | 256 | 130 | 7 | 33397691 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | EPB41L3 LUZP1 ASAP1 CGN DIAPH3 PLEC PARD3 PLEKHA7 DHX29 GOLGB1 | 5.52e-05 | 565 | 130 | 10 | 25468996 |
| Pubmed | TMCO5A DISC1 CFTR CEP290 CLPX CC2D2B STEEP1 SCN9A ANGPTL3 KLHL8 DHX29 | 5.65e-05 | 686 | 130 | 11 | 29987050 | |
| Pubmed | 5.77e-05 | 568 | 130 | 10 | 37774976 | ||
| Pubmed | CCNL2 PPP1R12A GIGYF1 DPF2 CLPX EPB41L3 LUZP1 SCML1 MORF4L1 ASCC3 PARD3 ANAPC5 ALPL NIN | 7.81e-05 | 1116 | 130 | 14 | 31753913 | |
| Interaction | PIBF1 interactions | CEP162 DISC1 CEP290 VPS33A PRPF18 MORF4L1 STEEP1 CEP135 CEP70 CDK5RAP2 AMOTL2 PLEKHA7 CFAP53 NIN | 3.30e-11 | 200 | 127 | 14 | int:PIBF1 |
| Interaction | CEP135 interactions | MIA3 CEP162 CEP290 GIGYF1 TEX9 CEP164 LUZP1 TBC1D31 CGN CEP135 CEP70 CDK5RAP2 GOLGB1 NIN | 1.89e-09 | 272 | 127 | 14 | int:CEP135 |
| Interaction | OFD1 interactions | CENPE DSP CEP162 DISC1 CEP290 GIGYF1 CEP164 LUZP1 TBC1D31 CEP135 CDK5RAP2 DIAPH3 ANAPC5 KLC1 NIN | 5.24e-09 | 347 | 127 | 15 | int:OFD1 |
| Interaction | NDC80 interactions | MIA3 CENPE CEP162 CEP290 VPS33A TEX9 CEP164 LUZP1 TBC1D31 CEP135 CDK5RAP2 DIAPH3 AMOTL2 NIN | 1.09e-08 | 312 | 127 | 14 | int:NDC80 |
| Interaction | ATG16L1 interactions | ACACB PPP1R12A FNBP4 NCBP1 GIGYF1 SPECC1L FAM98B TEX9 LCP1 PARP14 ITPR1 ITPR2 MED15 STK4 RBSN EIF2D SMC3 STEEP1 ROBO1 CDK5RAP2 DIAPH3 PLEC ASCC3 FMNL1 GOLGB1 LRRFIP2 | 1.30e-08 | 1161 | 127 | 26 | int:ATG16L1 |
| Interaction | PCM1 interactions | CENPE DSP CEP162 DISC1 CEP290 CEP57L1 TEX9 CEP164 LUZP1 TBC1D31 MORF4L1 CEP135 CDK5RAP2 DIAPH3 KLC1 NIN | 1.49e-08 | 434 | 127 | 16 | int:PCM1 |
| Interaction | KRT19 interactions | DSP CEP162 CFTR CEP290 CEP57L1 TEX9 CEP164 LUZP1 TBC1D31 CDK5RAP2 PLEC AMOTL2 NIN | 2.75e-08 | 282 | 127 | 13 | int:KRT19 |
| Interaction | CDC14A interactions | 3.46e-08 | 111 | 127 | 9 | int:CDC14A | |
| Interaction | YWHAH interactions | DSP CEP162 PPP1R12A CFTR CEP290 GIGYF1 SPECC1L EPB41L3 CCDC39 TMCC3 LUZP1 STK4 RBSN SNCAIP CGN CEP135 KIF5A PLEC AMOTL2 PARD3 USP48 PLEKHA7 KLC1 NIN | 8.72e-08 | 1102 | 127 | 24 | int:YWHAH |
| Interaction | CEP128 interactions | DSP CEP162 CEP290 VPS33A GIGYF1 TEX9 CEP164 LUZP1 TBC1D31 CEP135 ASCC3 NIN | 4.00e-07 | 297 | 127 | 12 | int:CEP128 |
| Interaction | NIN interactions | MIA3 CENPE CEP162 CEP290 VPS33A TEX9 CEP164 LUZP1 TBC1D31 CEP135 DIAPH3 KLC1 NIN | 4.48e-07 | 359 | 127 | 13 | int:NIN |
| Interaction | YWHAQ interactions | CEP162 DISC1 PPP1R12A CFTR FNDC5 MRPS27 GIGYF1 SPECC1L NEB EPB41L3 TMCC3 LUZP1 STK4 CGN ANKRD18A KIF5A PLEC AMOTL2 PARD3 USP48 PLEKHA7 GOLGB1 KLC1 | 4.62e-07 | 1118 | 127 | 23 | int:YWHAQ |
| Interaction | KIF3C interactions | 5.43e-07 | 26 | 127 | 5 | int:KIF3C | |
| Interaction | TBC1D31 interactions | 1.40e-06 | 56 | 127 | 6 | int:TBC1D31 | |
| Interaction | CCDC14 interactions | 1.60e-06 | 129 | 127 | 8 | int:CCDC14 | |
| Interaction | FBXO22 interactions | FLT1 ACACB CENPE PPP1R12A FNBP4 MRPS27 NEB LCP1 EPB41L3 RTF1 DDX46 GTF3C1 SMC3 SCN9A ASCC3 | 1.61e-06 | 540 | 127 | 15 | int:FBXO22 |
| Interaction | CEP63 interactions | 2.03e-06 | 179 | 127 | 9 | int:CEP63 | |
| Interaction | BICD2 interactions | CENPE VPS33A CCDC50 LCP1 PRPF18 LUZP1 ASAP1 PPP1R7 EIF2D CEP135 PLEC PLEKHA7 NIN | 3.01e-06 | 426 | 127 | 13 | int:BICD2 |
| Interaction | LIMA1 interactions | DISC1 CFTR FNDC4 CCDC50 GIGYF1 LUZP1 DDX46 PLEKHG6 CGN PLEC USP48 PLEKHA7 FMNL1 | 3.25e-06 | 429 | 127 | 13 | int:LIMA1 |
| Interaction | DISC1 interactions | DISC1 CEP290 CEP57L1 RIBC1 LAMC1 SPECC1L TEX9 EPB41L3 CEP164 LUZP1 RBSN SMC3 KIF3C | 3.25e-06 | 429 | 127 | 13 | int:DISC1 |
| Interaction | CEP43 interactions | 3.31e-06 | 190 | 127 | 9 | int:CEP43 | |
| Interaction | TEX9 interactions | 3.41e-06 | 37 | 127 | 5 | int:TEX9 | |
| Interaction | SYNPO interactions | 3.61e-06 | 192 | 127 | 9 | int:SYNPO | |
| Interaction | KIF7 interactions | 4.06e-06 | 146 | 127 | 8 | int:KIF7 | |
| Interaction | SASS6 interactions | 7.62e-06 | 159 | 127 | 8 | int:SASS6 | |
| Interaction | NME7 interactions | 7.98e-06 | 160 | 127 | 8 | int:NME7 | |
| Interaction | CALM3 interactions | FLT1 PPP1R12A CFTR CEP290 FNDC5 MRPS27 SPECC1L LUZP1 ITPR2 USP48 LRRFIP2 | 1.13e-05 | 343 | 127 | 11 | int:CALM3 |
| Interaction | BORCS6 interactions | 1.24e-05 | 170 | 127 | 8 | int:BORCS6 | |
| Interaction | LATS2 interactions | 1.50e-05 | 289 | 127 | 10 | int:LATS2 | |
| Interaction | MIB1 interactions | CEP162 CEP290 CCDC50 TEX9 TMCC3 LUZP1 TBC1D31 CEP135 ASCC3 NIN | 1.80e-05 | 295 | 127 | 10 | int:MIB1 |
| Interaction | CAPZA2 interactions | PPP1R12A CFTR SPECC1L LCP1 LUZP1 ITPR1 ITPR2 CGN CDK5RAP2 PLEC USP48 LRRFIP2 | 1.80e-05 | 430 | 127 | 12 | int:CAPZA2 |
| Interaction | LZTS2 interactions | FKBP6 DSP CEP290 VPS33A CEP57L1 GIGYF1 PRPF18 CEP164 MORF4L1 CGN CEP135 PARD3 PLEKHA7 | 2.15e-05 | 512 | 127 | 13 | int:LZTS2 |
| Interaction | TRIM52 interactions | 2.15e-05 | 133 | 127 | 7 | int:TRIM52 | |
| Interaction | TP53BP2 interactions | 2.24e-05 | 241 | 127 | 9 | int:TP53BP2 | |
| Interaction | MYO18A interactions | CEP162 PPP1R12A CFTR SPECC1L LUZP1 DDX46 CGN PLEC USP48 LRRFIP2 | 2.26e-05 | 303 | 127 | 10 | int:MYO18A |
| Interaction | YWHAZ interactions | CEP162 DISC1 PPP1R12A CFTR FNDC5 LAMC1 GIGYF1 NEB EPB41L3 PRPF18 TMCC3 LUZP1 ITPR1 CGN CDK5RAP2 KIF5A PLEC PARD3 USP48 PLEKHA7 KLC1 NIN | 2.44e-05 | 1319 | 127 | 22 | int:YWHAZ |
| Interaction | KDM1A interactions | ACACB DSP CEP162 PPP1R12A LAMC1 TEX9 EPB41L3 LUZP1 GTF3C1 USP38 CEP70 DIAPH3 PLEC ASCC3 OBI1 GOLGB1 KLC1 NIN | 2.52e-05 | 941 | 127 | 18 | int:KDM1A |
| Interaction | BICD1 interactions | 2.99e-05 | 250 | 127 | 9 | int:BICD1 | |
| Interaction | PDE6B interactions | 3.16e-05 | 29 | 127 | 4 | int:PDE6B | |
| Interaction | LUZP1 interactions | 3.22e-05 | 194 | 127 | 8 | int:LUZP1 | |
| Interaction | NINL interactions | CENPE DSP CEP162 CEP290 MRPS27 GIGYF1 TEX9 PRPF18 LUZP1 RBSN DIAPH3 PLEKHA7 | 3.34e-05 | 458 | 127 | 12 | int:NINL |
| Interaction | CEP170 interactions | 3.41e-05 | 318 | 127 | 10 | int:CEP170 | |
| Interaction | TXLNB interactions | 3.44e-05 | 97 | 127 | 6 | int:TXLNB | |
| Interaction | ACTR2 interactions | IQGAP2 PPP1R12A CFTR FNDC5 FAM98B LUZP1 SMC3 PARD3 USP48 NIN | 3.89e-05 | 323 | 127 | 10 | int:ACTR2 |
| Interaction | CEP131 interactions | 4.00e-05 | 200 | 127 | 8 | int:CEP131 | |
| Interaction | TJP1 interactions | 4.09e-05 | 325 | 127 | 10 | int:TJP1 | |
| Interaction | CEP89 interactions | 4.10e-05 | 147 | 127 | 7 | int:CEP89 | |
| Interaction | HTATIP2 interactions | 4.12e-05 | 61 | 127 | 5 | int:HTATIP2 | |
| Interaction | MYH7 interactions | 4.32e-05 | 101 | 127 | 6 | int:MYH7 | |
| Interaction | CALD1 interactions | 4.71e-05 | 265 | 127 | 9 | int:CALD1 | |
| Interaction | CCDC66 interactions | 4.72e-05 | 32 | 127 | 4 | int:CCDC66 | |
| Interaction | ACTB interactions | IQGAP2 PPP1R12A CFTR FNDC5 NCBP1 DPF2 NEB LCP1 LUZP1 PLEKHG6 SMC3 MORF4L1 TMCC2 CD81 DIAPH3 PLEC USP48 KLC1 LRRFIP2 | 4.80e-05 | 1083 | 127 | 19 | int:ACTB |
| Interaction | HAUS3 interactions | 4.83e-05 | 103 | 127 | 6 | int:HAUS3 | |
| Interaction | HAUS4 interactions | 5.10e-05 | 104 | 127 | 6 | int:HAUS4 | |
| Interaction | CEP20 interactions | 5.34e-05 | 33 | 127 | 4 | int:CEP20 | |
| Interaction | FMNL1 interactions | 6.63e-05 | 109 | 127 | 6 | int:FMNL1 | |
| Interaction | YWHAB interactions | CENPE CEP162 PPP1R12A CFTR FNDC5 GIGYF1 NEB EPB41L3 TMCC3 LUZP1 STK4 CGN KIF5A AMOTL2 PARD3 USP48 PLEKHA7 KLC1 | 6.66e-05 | 1014 | 127 | 18 | int:YWHAB |
| Interaction | DBN1 interactions | CEP162 DISC1 PPP1R12A CFTR SPECC1L LUZP1 SMC3 CGN USP48 NIPBL LRRFIP2 | 6.77e-05 | 417 | 127 | 11 | int:DBN1 |
| Interaction | RCOR1 interactions | ACACB DSP PPP1R12A VPS33A EPB41L3 LUZP1 DDX46 CEP135 PLEC ASCC3 OBI1 KLC1 | 6.91e-05 | 494 | 127 | 12 | int:RCOR1 |
| Interaction | FERMT3 interactions | 6.97e-05 | 68 | 127 | 5 | int:FERMT3 | |
| Interaction | WWTR1 interactions | PPP1R12A SPECC1L LUZP1 GTF3C1 CGN STEEP1 DIAPH3 AMOTL2 ASCC3 PARD3 KLC1 | 7.52e-05 | 422 | 127 | 11 | int:WWTR1 |
| Interaction | DTNBP1 interactions | 7.59e-05 | 162 | 127 | 7 | int:DTNBP1 | |
| Interaction | MYH9 interactions | CEP162 PPP1R12A CFTR FNDC5 CCDC50 SPECC1L PARP14 LUZP1 ITPR2 TBC1D31 PLEC USP48 CCDC180 KLC1 LRRFIP2 | 8.17e-05 | 754 | 127 | 15 | int:MYH9 |
| Interaction | HERC2 interactions | ANK2 CEP162 DISC1 CEP290 SPECC1L LCP1 ITPR2 DDX46 SMC3 CEP135 PLEC NIN | 8.20e-05 | 503 | 127 | 12 | int:HERC2 |
| Interaction | CCDC57 interactions | 8.52e-05 | 165 | 127 | 7 | int:CCDC57 | |
| Interaction | CARD9 interactions | 8.52e-05 | 165 | 127 | 7 | int:CARD9 | |
| Interaction | RPGRIP1L interactions | 9.14e-05 | 225 | 127 | 8 | int:RPGRIP1L | |
| Interaction | DAAM1 interactions | 9.16e-05 | 72 | 127 | 5 | int:DAAM1 | |
| Interaction | CAMSAP2 interactions | 9.89e-05 | 169 | 127 | 7 | int:CAMSAP2 | |
| Interaction | MAPRE1 interactions | CENPE CEP162 PPP1R12A CEP290 SPECC1L LUZP1 TBC1D31 CEP135 CDK5RAP2 DIAPH3 PLEC NIN | 1.01e-04 | 514 | 127 | 12 | int:MAPRE1 |
| Interaction | LATS1 interactions | MIA3 PPP1R12A CEP290 NEB STK4 CGN CEP70 CDK5RAP2 PLEC PARD3 NIN | 1.09e-04 | 440 | 127 | 11 | int:LATS1 |
| Interaction | KRT38 interactions | 1.10e-04 | 172 | 127 | 7 | int:KRT38 | |
| Interaction | PRPF18 interactions | 1.13e-04 | 120 | 127 | 6 | int:PRPF18 | |
| Interaction | YWHAE interactions | CENPE DISC1 PPP1R12A CFTR FNDC5 NCBP1 GIGYF1 EPB41L3 TMCC3 LUZP1 STK4 CGN KIF5A AMOTL2 PARD3 USP48 PLEKHA7 KLC1 LRRFIP2 NIN | 1.13e-04 | 1256 | 127 | 20 | int:YWHAE |
| Interaction | SYNE3 interactions | MIA3 CENPE LAMC1 GIGYF1 CEP164 TMCC3 CDK5RAP2 PLEC PLEKHA7 OBI1 NIN | 1.18e-04 | 444 | 127 | 11 | int:SYNE3 |
| Interaction | KCNA3 interactions | DNHD1 ANK2 DSP SPECC1L EPB41L3 LUZP1 SMC3 CGN ROBO1 CDK5RAP2 CARD11 DIAPH3 ASCC3 PARD3 DHX29 GOLGB1 | 1.18e-04 | 871 | 127 | 16 | int:KCNA3 |
| Interaction | SIPA1L1 interactions | 1.19e-04 | 174 | 127 | 7 | int:SIPA1L1 | |
| Interaction | ACTC1 interactions | DISC1 FNBP4 DPF2 LCP1 LUZP1 RTF1 DDX46 TMCC2 STEEP1 CDK5RAP2 PLEC USP48 GOLGB1 LRRFIP2 | 1.24e-04 | 694 | 127 | 14 | int:ACTC1 |
| Interaction | DIAPH1 interactions | 1.27e-04 | 176 | 127 | 7 | int:DIAPH1 | |
| Interaction | FGL2 interactions | 1.29e-04 | 16 | 127 | 3 | int:FGL2 | |
| Interaction | CEP290 interactions | 1.41e-04 | 179 | 127 | 7 | int:CEP290 | |
| Interaction | PCNT interactions | 1.47e-04 | 241 | 127 | 8 | int:PCNT | |
| Interaction | TBKBP1 interactions | 1.51e-04 | 80 | 127 | 5 | int:TBKBP1 | |
| Interaction | FAM133A interactions | 1.60e-04 | 81 | 127 | 5 | int:FAM133A | |
| Interaction | RAB11FIP2 interactions | 1.80e-04 | 83 | 127 | 5 | int:RAB11FIP2 | |
| Interaction | TCHP interactions | 1.83e-04 | 131 | 127 | 6 | int:TCHP | |
| Interaction | IL31 interactions | 1.86e-04 | 18 | 127 | 3 | int:IL31 | |
| Interaction | FHDC1 interactions | 1.86e-04 | 18 | 127 | 3 | int:FHDC1 | |
| Interaction | RNF123 interactions | DNAH3 CENPE DSP DISC1 CEP290 NCBP1 PARP14 CCDC39 ITPR2 PPP1R7 GTF3C1 ANKRD18A AMOTL2 USP48 LRRFIP2 | 2.16e-04 | 824 | 127 | 15 | int:RNF123 |
| Interaction | CEP55 interactions | 2.22e-04 | 256 | 127 | 8 | int:CEP55 | |
| Interaction | ACTN4 interactions | ANPEP PPP1R12A CFTR FNDC5 NCBP1 SPECC1L NEB CD81 USP48 FMNL1 | 2.26e-04 | 400 | 127 | 10 | int:ACTN4 |
| Interaction | AGPAT3 interactions | 2.37e-04 | 88 | 127 | 5 | int:AGPAT3 | |
| Interaction | FMNL3 interactions | 2.56e-04 | 49 | 127 | 4 | int:FMNL3 | |
| Interaction | CCDC8 interactions | DSP CEP290 LAMC1 SPECC1L ITPR2 GTF3C1 SMC3 GLE1 CGN PLEC ASCC3 NIPBL GOLGB1 | 2.59e-04 | 656 | 127 | 13 | int:CCDC8 |
| Interaction | C6orf141 interactions | 2.91e-04 | 92 | 127 | 5 | int:C6orf141 | |
| Interaction | PHLDB2 interactions | 2.94e-04 | 143 | 127 | 6 | int:PHLDB2 | |
| Interaction | YWHAG interactions | DSP CEP162 DISC1 PPP1R12A CFTR FNDC5 GIGYF1 SPECC1L EPB41L3 TMCC3 LUZP1 STK4 CGN KIF5A AMOTL2 PARD3 USP48 PLEKHA7 KLC1 | 3.03e-04 | 1248 | 127 | 19 | int:YWHAG |
| Interaction | TRIM36 interactions | 3.05e-04 | 144 | 127 | 6 | int:TRIM36 | |
| Interaction | DCTN1 interactions | CENPE CEP162 DISC1 CFTR CEP290 SPECC1L LUZP1 DIAPH3 USP48 DHX29 NIN | 3.12e-04 | 497 | 127 | 11 | int:DCTN1 |
| Interaction | CAPZB interactions | DISC1 PPP1R12A CFTR MRPS27 NCBP1 SPECC1L LCP1 LUZP1 ITPR1 ITPR2 USP48 DHX29 NIPBL OBI1 KLC1 LRRFIP2 NIN | 3.17e-04 | 1049 | 127 | 17 | int:CAPZB |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 5.93e-05 | 3 | 81 | 2 | 297 | |
| GeneFamily | Transmembrane and coiled-coil domain containing | 5.93e-05 | 3 | 81 | 2 | 774 | |
| GeneFamily | Ankyrin repeat domain containing | 1.06e-04 | 242 | 81 | 7 | 403 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.61e-04 | 181 | 81 | 6 | 694 | |
| GeneFamily | EF-hand domain containing|Plakins | 5.45e-04 | 8 | 81 | 2 | 939 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 1.14e-03 | 46 | 81 | 3 | 622 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | IQGAP2 CENPE CEP290 EPB41L3 ITPR1 ITPR2 DDX46 SMC3 SCML1 CEP70 CDK5RAP2 DIAPH3 USP48 DHX29 NIPBL OBI1 GOLGB1 NIN | 3.03e-09 | 656 | 127 | 18 | M18979 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | CENPE CEP290 NCBP1 FAM98B TEX9 LUZP1 STK4 DDX46 SMC3 CEP135 NIPBL | 2.61e-08 | 192 | 129 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | CENPE CEP162 CEP290 FAM98B TEX9 LUZP1 DDX46 SMC3 CEP135 CEP70 NIPBL LRRFIP2 | 4.48e-07 | 311 | 129 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | PPP1R12A CEP57L1 LCP1 TBC1D31 GTF3C1 USP38 GLE1 CDK5RAP2 GOLGB1 | 1.99e-06 | 185 | 129 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | ACACB CENPE PPP1R12A CEP290 CEP57L1 TEX9 LCP1 LUZP1 DDX46 SNCAIP TBC1D31 USP38 SMC3 GLE1 CEP70 CDK5RAP2 NIPBL FMNL1 GOLGB1 | 8.37e-06 | 989 | 129 | 19 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | CENPE CEP162 CEP290 NCBP1 FAM98B TEX9 CEP164 LUZP1 STK4 RBSN DDX46 SMC3 CEP135 USP48 ANAPC5 NIPBL LRRFIP2 | 1.17e-05 | 831 | 129 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | CENPE PPP1R12A CEP290 LUZP1 DDX46 SNCAIP SMC3 CEP70 CDK5RAP2 NIPBL FMNL1 GOLGB1 | 1.32e-05 | 432 | 129 | 12 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | CENPE CEP290 NCBP1 FAM98B TEX9 LUZP1 STK4 PPP1R7 DDX46 SMC3 CEP135 ASCC3 NIPBL | 2.21e-05 | 532 | 129 | 13 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | CENPE PPP1R12A CEP290 CEP57L1 TEX9 LUZP1 DDX46 TBC1D31 GTF3C1 USP38 SMC3 CDK5RAP2 NIPBL GOLGB1 | 2.95e-05 | 629 | 129 | 14 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000 | IQGAP2 PPP1R12A LAMC1 CCDC50 DPF2 CEP164 DDX46 ASCC3 PLEKHA7 | 3.17e-05 | 261 | 129 | 9 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | PPP1R12A CEP57L1 CCDC50 FAM98B ITPR2 RTF1 TBC1D31 GTF3C1 USP38 ZNF334 CDK5RAP2 DHX29 GOLGB1 | 4.03e-05 | 564 | 129 | 13 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 8.81e-05 | 298 | 129 | 9 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 8.82e-05 | 232 | 129 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.38e-04 | 129 | 129 | 6 | gudmap_developingKidney_e14.5 whole kidney - wildtype_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | CENPE CEP290 CEP57L1 TEX9 LUZP1 STK4 DDX46 SMC3 CEP135 PARD3 NIPBL | 1.39e-04 | 469 | 129 | 11 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 1.44e-04 | 186 | 129 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | CENPE CEP290 NCBP1 FAM98B TEX9 LUZP1 STK4 DDX46 SMC3 CEP135 NIPBL | 2.34e-04 | 498 | 129 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | ANK2 IQGAP2 CENPE CEP162 CEP290 CCDC50 GOLM1 FAM98B STK4 DDX46 ZNF334 SMC3 CEP135 CEP70 RNF207 NIPBL OBI1 | 2.36e-04 | 1060 | 129 | 17 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | CENPE CEP162 CEP290 CEP57L1 CLPX CEP164 LUZP1 RBSN CEP70 USP48 ANAPC5 NIPBL LRRFIP2 NIN | 2.85e-04 | 780 | 129 | 14 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | CENPE CEP162 CEP290 NCBP1 GOLM1 FAM98B TEX9 LUZP1 STK4 DDX46 SMC3 CEP135 CEP70 ANAPC5 NIPBL LRRFIP2 | 3.31e-04 | 989 | 129 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 4.12e-04 | 291 | 129 | 8 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | CEP162 CEP290 GOLM1 TEX9 CCDC39 SMC3 ANKRD18A CFAP53 NIPBL GOLGB1 | 3.84e-10 | 199 | 130 | 10 | 61b1ed2db71b96157b92b7535d1955a4033098da |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | CCNL2 CENPE CEP290 CEP164 RTF1 DDX46 CDK5RAP2 ANKRD18A GOLGB1 | 6.87e-09 | 197 | 130 | 9 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e |
| ToppCell | COVID-19-Epithelial-Ionocytes|Epithelial / Condition, Lineage and Cell class | 6.28e-08 | 181 | 130 | 8 | 4a8d4f2709c1b25f908867f1b2fae1d2d0abf1d4 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.51e-08 | 191 | 130 | 8 | d9506b88d806aadd4c2b9bf86fe994c47799e7f6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.51e-08 | 191 | 130 | 8 | b42c54308abe1241cc38ddce96b9d38d07983891 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.51e-08 | 191 | 130 | 8 | 9aabbc65430e2233b8f2d3fff9face7807b88b48 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.22e-07 | 171 | 130 | 7 | 845f312f8cbe29d820da25f0e6d75deb382bbfd8 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-06 | 184 | 130 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-06 | 184 | 130 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-06 | 184 | 130 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.31e-06 | 187 | 130 | 7 | ff26a533d310126521efe1d05cf8b9d32e524550 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.41e-06 | 189 | 130 | 7 | cd4746ea6ae48a7dd14a2960d38d9445a738cf2c | |
| ToppCell | COVID-19-lung-CD8+_T_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.51e-06 | 191 | 130 | 7 | 543f8ae07cc2e6950c888115a5ca9445e3c0f618 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-06 | 194 | 130 | 7 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.92e-06 | 198 | 130 | 7 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 1.99e-06 | 199 | 130 | 7 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.99e-06 | 199 | 130 | 7 | 0d6463e368fd611a17327322413fad145f3c7f32 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 1.99e-06 | 199 | 130 | 7 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Mild/Remission-B_intermediate-10|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.99e-06 | 136 | 130 | 6 | 1b3c6edcbe0eb674d2d9c838e83ebe2b93e3eec1 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.36e-06 | 155 | 130 | 6 | 8e239470799426ea474a36f57e1b7e0d9365ca5f | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.36e-06 | 159 | 130 | 6 | 4000ed0d3b7d488722bcd0042fa2ff4405aaab82 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.36e-06 | 159 | 130 | 6 | 7619d0d49738dd08daf01b42664691a5323aa793 | |
| ToppCell | NS-control-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.42e-06 | 166 | 130 | 6 | 6d9fb239f69ba519844f593c00d515e1aac4ff50 | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 9.74e-06 | 167 | 130 | 6 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.74e-06 | 167 | 130 | 6 | ced6ed9b412739c6ced622523347c10295edbf53 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-05 | 168 | 130 | 6 | e870d2e69316406f45112ed0bf324b24f902a99e | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.01e-05 | 168 | 130 | 6 | 6a233045638cb83dab64789b996b7598c325001e | |
| ToppCell | 368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-05 | 168 | 130 | 6 | 403aba73a0f9ffb32252288d075fad8a588ca440 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.36e-05 | 177 | 130 | 6 | 6d89042bda8e244babb68929e84b25edcb545a77 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.36e-05 | 177 | 130 | 6 | daaccf1249dcf816df4caca695a944f53078291a | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.36e-05 | 177 | 130 | 6 | 338bdda26796bf4e16072878c070212d1006cf57 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.36e-05 | 177 | 130 | 6 | 99500aed584f793aaf308f8afbf5d1c6a9b4ee55 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.36e-05 | 177 | 130 | 6 | c5a16f984c836dbf7d0faf061677844167ab612a | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.40e-05 | 178 | 130 | 6 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | NS-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.45e-05 | 179 | 130 | 6 | 65a96bee7bc28f5bfc20f0fd92bcc0ab2eb5e06c | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-05 | 181 | 130 | 6 | 40df0afcb6848202da54670e84f22d7c3a515d01 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-05 | 181 | 130 | 6 | 2b53a65ca5616a7b9f64232c3e0b7212d1e2f063 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-05 | 181 | 130 | 6 | 6aef84616e8d2faf54b7e9e6cd02f33c3066dabc | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-05 | 181 | 130 | 6 | 40d3829ae4aaf81e8616c3499ff8933137fc1cc4 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.64e-05 | 183 | 130 | 6 | ba43bca2b45be1008eebd3f033cecb061fb3a966 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-05 | 183 | 130 | 6 | 31ab55d5f3639f5964541d5eae23044dbda3356e | |
| ToppCell | LPS-IL1RA|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.69e-05 | 184 | 130 | 6 | c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc | |
| ToppCell | critical-Epithelial-Ionocyte|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.69e-05 | 184 | 130 | 6 | 58d36577eff814d46d72f031f3533d71549e3d6e | |
| ToppCell | Control-T_cells-CD8+_T_cells|Control / group, cell type (main and fine annotations) | 1.74e-05 | 185 | 130 | 6 | 02ab64c0166c0646d1d4c6ed110ef0b75a1096d0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-05 | 185 | 130 | 6 | 45890fa81c65a48f4fdec164a4c8d0e2831243c0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-05 | 185 | 130 | 6 | 585bcfdff85bf43f5aa4cd1b39f7dcf1c78d7b02 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-05 | 185 | 130 | 6 | 898a093757f86be3e18d2ef1f16a71f50ef81dc3 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.80e-05 | 186 | 130 | 6 | 7582b5154d8e5a4434817b5ab77a10b789ea2288 | |
| ToppCell | Control-T_cells|Control / group, cell type (main and fine annotations) | 1.85e-05 | 187 | 130 | 6 | f4e8e0eba58da89b56587667555a5d4754e108c7 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-05 | 187 | 130 | 6 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.91e-05 | 188 | 130 | 6 | 1f912ea015f50570e848259d948a0ba682d64bb4 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.91e-05 | 188 | 130 | 6 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.91e-05 | 188 | 130 | 6 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.91e-05 | 188 | 130 | 6 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 1.91e-05 | 188 | 130 | 6 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.97e-05 | 189 | 130 | 6 | df30478b288084a1bd48f660409dcc784040897c | |
| ToppCell | moderate-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.97e-05 | 189 | 130 | 6 | 6011b747e27d61d222380a7bffdd921a68e9b657 | |
| ToppCell | CF-Lymphoid-B_cell|CF / Disease state, Lineage and Cell class | 2.02e-05 | 190 | 130 | 6 | 374d8fd63c733178acab07682ed1519693efab45 | |
| ToppCell | Control-T_cells-CD4+_T_cells|Control / group, cell type (main and fine annotations) | 2.02e-05 | 190 | 130 | 6 | 0733be5e54fe15d6d6ea51c154a95258e83f1b92 | |
| ToppCell | COVID-19-kidney-NK|kidney / Disease (COVID-19 only), tissue and cell type | 2.02e-05 | 190 | 130 | 6 | e3ca3c9fb9e27670a5dd128dd6564ff98a57159e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-05 | 190 | 130 | 6 | b772a5d281fe016f259ddda80d6f33d949dcac2b | |
| ToppCell | facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.02e-05 | 190 | 130 | 6 | 2655df8c0883dd811fa7617301f9c4b0a4dd55ec | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.09e-05 | 191 | 130 | 6 | acd844b477a069b2dcf07b2998e1b5c87dc0eb94 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.09e-05 | 191 | 130 | 6 | bda8faf92495c8b362850c0aff4fc6fbdd9c563b | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.09e-05 | 191 | 130 | 6 | 6880fb348bb0915db9a5da4f3566ca9ff93ed258 | |
| ToppCell | Myeloid-Myeloid-B_(Activated_Macrophage)|Myeloid / shred on cell class and cell subclass (v4) | 2.09e-05 | 191 | 130 | 6 | 7bf125249af1e8bb138ed4d999fdd74b03ab2447 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.09e-05 | 191 | 130 | 6 | 0ba5b112a82e489f5a21966f78a403a7436ce73b | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.15e-05 | 192 | 130 | 6 | b5cdc2dae3154b1e4ade88f841f38584402ffe33 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.15e-05 | 192 | 130 | 6 | 2d8d5a38e205339eda9c8aca1ca9ba3dcbe5ae56 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.21e-05 | 193 | 130 | 6 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.21e-05 | 193 | 130 | 6 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | CF-Lymphoid|CF / Disease state, Lineage and Cell class | 2.21e-05 | 193 | 130 | 6 | 11de07d13a7da223990b56fa89ba7fc1c3dd0122 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-05 | 193 | 130 | 6 | 1f978e102a029a6beb10913052cd0a20c7253e8e | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.28e-05 | 194 | 130 | 6 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | control-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.28e-05 | 194 | 130 | 6 | 267e213e8efe53aadfe553a2ca010a0e3b4b8939 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-05 | 194 | 130 | 6 | 4dfc890bacf133cfb6ec7c8b73f084f2491cf78e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.28e-05 | 194 | 130 | 6 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.34e-05 | 195 | 130 | 6 | d211a836cf711fdb91b10d512f09d462be937cc5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-05 | 195 | 130 | 6 | 7b6c69df943842b566a596e30bb50dbe80dccc83 | |
| ToppCell | COVID-19-kidney-T-cells-1|kidney / Disease (COVID-19 only), tissue and cell type | 2.48e-05 | 197 | 130 | 6 | 9bb7faf4ef63cca4d06c60e6c05a9616fdb6b98e | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Macroglial|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.48e-05 | 197 | 130 | 6 | 965d5a3f8c9b12cb8a8d3429702ae29ebd8c6122 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Macroglial-Astroglia|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.48e-05 | 197 | 130 | 6 | 3f088eb29197bc575400d6dafd8083e69e4a149f | |
| ToppCell | Immune|World / Lineage, Cell type, age group and donor | 2.55e-05 | 198 | 130 | 6 | 65681b54d13c6997bd90a1c2a12314a80e964fe3 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 2.55e-05 | 198 | 130 | 6 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | Fetal_29-31_weeks-Immune|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.55e-05 | 198 | 130 | 6 | 5dff131356b8c22743bd27b2b21f86ee6e4a0a0d | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 2.55e-05 | 198 | 130 | 6 | 629d674a9c9108c1acb3f7af57bbdbf34bb0528e | |
| ToppCell | Adult-Immune|Adult / Lineage, Cell type, age group and donor | 2.55e-05 | 198 | 130 | 6 | 9bfd7b88aa646eaf5eddb15cf985c7ca910cb35e | |
| ToppCell | PSB|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.55e-05 | 198 | 130 | 6 | 4e6b0d1abc55d7a0d89bd7ecf0f13dc5bed66626 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.63e-05 | 199 | 130 | 6 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 2.63e-05 | 199 | 130 | 6 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 2.63e-05 | 199 | 130 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_GZMK+|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.70e-05 | 200 | 130 | 6 | 7a9c3f51d4a8fda5f1b7e0be6fcf9c1c92fffe99 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.70e-05 | 200 | 130 | 6 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.70e-05 | 200 | 130 | 6 | 20ffb3436d08042f77800513e6ddb3bbc38ae6fe | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.70e-05 | 200 | 130 | 6 | e0cec0a844b7c1f8edee4c005af27766754e470a | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.70e-05 | 200 | 130 | 6 | c6c2b39359c65c9444987d02d1c899dff2ad1366 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.70e-05 | 200 | 130 | 6 | 66fb892bda1d29e67a65717e85f2ec221f520b2a | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.70e-05 | 200 | 130 | 6 | 9de4d6ebb7e9bee5d811519eb05913ef30f70786 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 2.70e-05 | 200 | 130 | 6 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_GZMK+|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.70e-05 | 200 | 130 | 6 | 510d84bf7a4621b079e5a7330d25e04508c84a49 | |
| Drug | PNU-0293363 [326823-19-2]; Down 200; 10uM; PC3; HT_HG-U133A | CENPE PPP1R12A MRPS27 EPB41L3 ASAP1 SCML1 CDK5RAP2 PLEC ANAPC5 SLC35A5 | 1.67e-07 | 196 | 128 | 10 | 6563_DN |
| Disease | Hypoxic Brain Damage | 1.75e-05 | 2 | 124 | 2 | C1140716 | |
| Disease | Anoxic Encephalopathy | 1.75e-05 | 2 | 124 | 2 | C0003132 | |
| Disease | Brain Hypoxia | 1.75e-05 | 2 | 124 | 2 | C1527348 | |
| Disease | Anoxia of brain | 1.75e-05 | 2 | 124 | 2 | C0995195 | |
| Disease | Autosomal recessive primary microcephaly | 3.18e-05 | 15 | 124 | 3 | cv:C3711387 | |
| Disease | acute respiratory distress syndrome | 1.05e-04 | 4 | 124 | 2 | EFO_1000637 | |
| Disease | Macrostomia | 1.05e-04 | 4 | 124 | 2 | C0024433 | |
| Disease | factor VIII measurement, coronary artery disease | 1.18e-04 | 113 | 124 | 5 | EFO_0001645, EFO_0004630 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 1.45e-04 | 118 | 124 | 5 | EFO_0001645, EFO_0004629 | |
| Disease | preeclampsia, fetal genotype effect measurement | 1.74e-04 | 5 | 124 | 2 | EFO_0000668, EFO_0007959 | |
| Disease | response to platinum based chemotherapy, cytotoxicity measurement | 1.74e-04 | 5 | 124 | 2 | EFO_0004647, EFO_0006952 | |
| Disease | Congenital muscular hypertrophy-cerebral syndrome | 1.74e-04 | 5 | 124 | 2 | C1802395 | |
| Disease | Cornelia de Lange Syndrome 3 | 1.74e-04 | 5 | 124 | 2 | C1853099 | |
| Disease | Cornelia de Lange Syndrome 1 | 1.74e-04 | 5 | 124 | 2 | C4551851 | |
| Disease | De Lange syndrome | 2.60e-04 | 6 | 124 | 2 | cv:C0270972 | |
| Disease | Cornelia de Lange syndrome (implicated_via_orthology) | 2.60e-04 | 6 | 124 | 2 | DOID:11725 (implicated_via_orthology) | |
| Disease | Aortic Diseases | 2.60e-04 | 6 | 124 | 2 | C0003493 | |
| Disease | attention function measurement | 4.14e-04 | 148 | 124 | 5 | EFO_0007636 | |
| Disease | diabetic nephropathy | 4.40e-04 | 150 | 124 | 5 | EFO_0000401 | |
| Disease | alcohol-related neurodevelopmental disorder (implicated_via_orthology) | 4.82e-04 | 8 | 124 | 2 | DOID:0050667 (implicated_via_orthology) | |
| Disease | nemaline myopathy (implicated_via_orthology) | 4.82e-04 | 8 | 124 | 2 | DOID:3191 (implicated_via_orthology) | |
| Disease | cleft palate (implicated_via_orthology) | 4.82e-04 | 8 | 124 | 2 | DOID:674 (implicated_via_orthology) | |
| Disease | Cornelia De Lange Syndrome | 4.82e-04 | 8 | 124 | 2 | C0270972 | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 5.07e-04 | 37 | 124 | 3 | DOID:0050545 (implicated_via_orthology) | |
| Disease | aspirin use measurement | 5.93e-04 | 39 | 124 | 3 | EFO_0007013 | |
| Disease | Marfan Syndrome, Type I | 6.19e-04 | 9 | 124 | 2 | C4721845 | |
| Disease | Inherited neuropathies | 6.39e-04 | 40 | 124 | 3 | C0598589 | |
| Disease | cystic kidney disease (implicated_via_orthology) | 7.71e-04 | 10 | 124 | 2 | DOID:2975 (implicated_via_orthology) | |
| Disease | Marfan Syndrome | 9.40e-04 | 11 | 124 | 2 | C0024796 | |
| Disease | immature platelet count | 1.06e-03 | 106 | 124 | 4 | EFO_0803544 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 1.12e-03 | 12 | 124 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | Renal dysplasia and retinal aplasia (disorder) | 1.12e-03 | 12 | 124 | 2 | C0403553 | |
| Disease | Ciliopathies | 1.22e-03 | 110 | 124 | 4 | C4277690 | |
| Disease | coronary artery disease, factor VII measurement | 1.26e-03 | 111 | 124 | 4 | EFO_0001645, EFO_0004619 | |
| Disease | immature platelet fraction | 1.39e-03 | 114 | 124 | 4 | EFO_0009187 | |
| Disease | factor XI measurement, coronary artery disease | 1.43e-03 | 115 | 124 | 4 | EFO_0001645, EFO_0004694 | |
| Disease | Kawasaki disease (is_marker_for) | 1.54e-03 | 14 | 124 | 2 | DOID:13378 (is_marker_for) | |
| Disease | coronary artery disease | FLT1 MIA3 CFTR LAMC1 SPECC1L LCP1 RTF1 MORF4L1 CEP135 PLCL1 USP48 PLEKHA7 HECA | 1.57e-03 | 1194 | 124 | 13 | EFO_0001645 |
| Disease | immature platelet measurement | 1.63e-03 | 119 | 124 | 4 | EFO_0803541 | |
| Disease | vitamin K-dependent protein C measurement | 1.77e-03 | 15 | 124 | 2 | EFO_0008318 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 2.12e-03 | 128 | 124 | 4 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 2.12e-03 | 128 | 124 | 4 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 2.12e-03 | 128 | 124 | 4 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 2.12e-03 | 128 | 124 | 4 | C1306837 | |
| Disease | Renal Cell Carcinoma | 2.12e-03 | 128 | 124 | 4 | C0007134 | |
| Disease | mosquito bite reaction itch intensity measurement | 2.18e-03 | 129 | 124 | 4 | EFO_0008377 | |
| Disease | Kuhnt-Junius degeneration (is_implicated_in) | 2.29e-03 | 17 | 124 | 2 | DOID:10873 (is_implicated_in) | |
| Disease | coronary artery disease, plasminogen activator inhibitor 1 measurement | 2.39e-03 | 63 | 124 | 3 | EFO_0001645, EFO_0004792 | |
| Disease | Hypertriglyceridemia | 2.86e-03 | 19 | 124 | 2 | EFO_0004211 | |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 3.36e-03 | 71 | 124 | 3 | EFO_0001645, EFO_0004791 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 3.58e-03 | 148 | 124 | 4 | C0279702 | |
| Disease | Autosomal Recessive Primary Microcephaly | 3.83e-03 | 22 | 124 | 2 | C3711387 | |
| Disease | Primary microcephaly | 3.83e-03 | 22 | 124 | 2 | C0431350 | |
| Disease | Bronchiectasis | 3.83e-03 | 22 | 124 | 2 | C0006267 | |
| Disease | fibrinogen measurement, coronary artery disease | 4.12e-03 | 154 | 124 | 4 | EFO_0001645, EFO_0004623 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KLQQLEASYACQEKE | 131 | Q8N6Q1 | |
| AKLLAQSYEQQQEQE | 421 | Q9Y2J4 | |
| QEKNNEYCLQDIDDK | 21 | A1L162 | |
| ELENQAALTNLKQKY | 106 | Q96DE9 | |
| INYAKKNDLVDADNK | 416 | P41214 | |
| HLQKQAEYEKQLEQL | 841 | Q8IVF6 | |
| AEYEKQLEQLNKDNT | 846 | Q8IVF6 | |
| GAINKIQDFLQKQEY | 366 | P13569 | |
| AQLQKRYKDLEQQDC | 71 | Q8IVM0 | |
| IAKLLQDANYNVEKA | 336 | O76031 | |
| LQKQAEYEKQLEQLN | 851 | A2A2Z9 | |
| EYEKQLEQLNKDNTA | 856 | A2A2Z9 | |
| AQLENEKQKVAELYS | 581 | Q69YQ0 | |
| LGYQVKDSKVEQQDN | 551 | Q53GS7 | |
| KDLLQTVEDQYKQLN | 176 | Q9Y5C1 | |
| TEYELQQLEQFKKDN | 911 | P15144 | |
| YKQLEEDLDNNPKIQ | 676 | Q96M86 | |
| LENEYLDQANDVINK | 1086 | Q9P1Z9 | |
| IKVNENKYENVDLLC | 666 | Q9NSV4 | |
| YAEQQNEEEKNENSK | 236 | Q7Z478 | |
| DYEDDQEQIKKQKAN | 156 | Q6DHV5 | |
| KLQKLQEDAVENDDY | 356 | Q9NRI5 | |
| KDVKQFYDQALQQAV | 121 | P60033 | |
| LEEQEYKLQKEQNLN | 1206 | Q96SN8 | |
| DALTLQKYAQQDDNK | 156 | Q9UFE4 | |
| NKAEKEIYALENTLQ | 686 | Q9UFE4 | |
| QQIDNIKAYIFDAKQ | 741 | Q9H1K0 | |
| NEQKYADAVKNFLDL | 546 | Q14644 | |
| NNDKEQELQNLLDKY | 541 | Q8HWS3 | |
| VSNQDVDNYKQIKAD | 1101 | Q14571 | |
| DININSIKDYKINSN | 161 | Q9Y5F9 | |
| KQRELQKANQEQYAE | 111 | Q9UBU8 | |
| NNNYANVELIVDIAK | 326 | O00763 | |
| IENLNEAKNYFAKVD | 691 | Q9UJX4 | |
| KQELEDNDKYQQFRL | 2141 | Q01484 | |
| EQNLNSAYKLQLEKV | 3706 | Q86XX4 | |
| LKKQQELAAAALYQQ | 551 | O75420 | |
| QLKESLKANNYNEAV | 111 | Q09161 | |
| SQDVDNYKQIKQDLD | 1116 | Q14643 | |
| VDLEKDDYQKVVCNN | 106 | Q9UBI9 | |
| AQYLKEKLNNEIVAN | 116 | Q0VAK6 | |
| KYDDNQKLAQLSENE | 91 | Q13191 | |
| LYAKLQAVKAEIQDQ | 591 | O14782 | |
| TENLNDDEKLNNAKY | 571 | P13796 | |
| KAEVTLNNTIYKNDN | 126 | Q96RD9 | |
| DLNIENEKQVYNAAI | 221 | Q9P2G9 | |
| EVKNLYNNILSDKNS | 2211 | Q6KC79 | |
| LNCSKNKDLYQEQVE | 336 | Q5W0B1 | |
| QAEEQQYLDKLKQLS | 526 | Q96RN5 | |
| YAKKNVEQNNLSDLI | 141 | Q86W50 | |
| NEKNNLIYQVDTLKD | 391 | Q9Y608 | |
| DQAQETLKYALELQK | 31 | P05186 | |
| EYQELNELQKKLNIN | 1471 | Q460N5 | |
| QAQAALQKLKAEEYV | 506 | Q3KR16 | |
| YGEQALIIDQKNAKA | 241 | O75344 | |
| AYQQQSQEAEKEEKR | 456 | Q96M91 | |
| ANLQENLANKEKAVA | 751 | Q66GS9 | |
| KDEPSKYNQQQALID | 331 | Q8NHQ1 | |
| KKYVDLLDNTAEQNI | 611 | Q8TD57 | |
| ELELANKQYNELTAK | 961 | O15078 | |
| DQDYVNLKNQIIKAE | 166 | Q96S94 | |
| YDIIKDNDSNNNPKE | 191 | Q9H6D8 | |
| RFDQQKNDYDQLQKA | 1131 | P15924 | |
| EAQYQEAPVEKNNLK | 266 | Q9HC77 | |
| EYQQNLKGENEQLKI | 81 | Q4G0S7 | |
| QELEEKLNILNNNYK | 376 | O14791 | |
| EKLAADLYNIKQTQD | 266 | Q9ULH1 | |
| ELFKLNQDNYILQAK | 661 | Q5TB80 | |
| KNSQLDKNSEVYQEV | 136 | Q52LJ0 | |
| KSKNNDLQDNYLSEQ | 316 | Q86V48 | |
| DLQDNYLSEQNKNKL | 321 | Q86V48 | |
| DLVAIQNKNEIDYLN | 66 | P16109 | |
| ESDKLQVQIQAYLDN | 366 | O95466 | |
| QKLQLELEKLQADYE | 736 | Q12840 | |
| YEQAKNISQDLEKQA | 1236 | P11047 | |
| KKNKQERDEDNLNYT | 526 | A6NGE4 | |
| EAAQYKKALENETNE | 86 | Q8IYX8 | |
| NKLYQDEKAVLVNNI | 96 | Q8NBJ4 | |
| IAEQLAEKINAKLNY | 896 | Q7L014 | |
| DLYDNQIKKIENLEA | 126 | Q15435 | |
| NDELVKVKDDNYNLA | 191 | Q9BXL7 | |
| AVIDNFVKKLEENYN | 126 | Q9NXZ2 | |
| ENDIQLYQSQLEAKK | 666 | Q02224 | |
| QLEYQQLEDDKLSQK | 76 | Q9Y2J2 | |
| AKKEAVSLNVNENNY | 371 | Q6NVV3 | |
| RDQNKYKDAANLLND | 266 | Q07866 | |
| ANKEQYEQLSQSEKN | 361 | Q8TEW0 | |
| QREQAKQEYQAQKAA | 396 | Q92552 | |
| ELSIKEALNYKFNDQ | 476 | Q92541 | |
| LLQAVQSQYEEKDKA | 261 | Q6ZRF8 | |
| DSYAQNAKVIEKQLE | 176 | Q9H5V9 | |
| QVIYDALQNLDKKID | 66 | Q9UN30 | |
| EDTEANKEKNLEQYN | 421 | Q9UQE7 | |
| NKEKNLEQYNKLDQD | 426 | Q9UQE7 | |
| LEQYNKLDQDLNEVK | 431 | Q9UQE7 | |
| YEKNLTENQEALAKE | 831 | Q96DN5 | |
| EYLKLANNADKQQVS | 316 | O75069 | |
| GNVAEYLKLVNNADK | 91 | Q9ULS5 | |
| IQYEQAKFQELLDKQ | 221 | B4DZS4 | |
| IQYEQAKFQELLDKQ | 126 | Q5H9J9 | |
| ENTELVQKLSNYEQK | 1226 | Q5JRA6 | |
| KLQDAAEQLKQYEIN | 581 | Q8N3X1 | |
| AEKLAEYENLTNKLQ | 491 | Q8N4C6 | |
| NALNKKAAFYEEQIN | 1426 | Q13576 | |
| EYSLFQKDKQEQNIP | 106 | Q7RTY7 | |
| YDIIKDNEPNNNKEK | 176 | Q8NAU1 | |
| NEYLKLENDVEQLKQ | 776 | Q6IQ23 | |
| QAEDLNTKKENYISN | 1026 | Q15858 | |
| NNESDDQKNQKVVEY | 91 | Q9Y6H5 | |
| EQAALNAAKEKALQQ | 736 | Q9UPV0 | |
| VTKQDNYNEEVADLK | 16 | Q8N3C0 | |
| KQALQQLQAQLEDYK | 866 | Q9P2M7 | |
| NKLDQEVQKDAQYRF | 221 | Q96M20 | |
| VQISKNKEYLDANDL | 321 | Q15111 | |
| NQNYPDIDDALEKNK | 76 | Q9HCZ1 | |
| KLYQEKDALQEIYNQ | 276 | Q9NRZ7 | |
| LANEQKAQQDYLNSV | 346 | Q8N443 | |
| ANIYNEKILKEGNQL | 246 | Q9BS91 | |
| NDVQALNKLLKYEDC | 96 | Q9H1D0 | |
| DLLKEKASIYQNQNS | 376 | Q92785 | |
| NELLVDNKAAQYFVK | 421 | Q8WWQ8 | |
| IVEQNKLNKDYRAND | 1116 | Q9Y6N7 | |
| NLNVTEEKYQEALAK | 61 | P04179 | |
| LQDAQDEKEQLNEYK | 901 | Q15149 | |
| TKDNKLYLQEQELNA | 981 | Q8NB14 | |
| NVYSANQKIQDAQDK | 266 | Q99541 | |
| LEYFEQKEKENQINS | 396 | Q13043 | |
| AELEQPDQAQSAYKK | 51 | Q6PGP7 | |
| TDKVNNYIEDCIAQK | 386 | Q96AX1 | |
| YIINQAKKENTAAEN | 1136 | Q12789 | |
| VLNLAYNKINKIADE | 316 | O60602 | |
| DLLQANVQQDGKDYI | 1156 | P17948 | |
| RLKNQLNEDYKTVNN | 566 | Q86UV5 | |
| DLKAALDKIDQQYLN | 126 | Q99633 | |
| LFEEANKKYDGLQQQ | 256 | Q8N6V9 | |
| KQQKDDYNRLQEQFD | 1206 | Q14789 | |
| EVQLQQNKELENKYA | 2556 | Q14789 | |
| YEQILAENEKLKAQL | 936 | O14974 | |
| DQNDIIQAKKAYDLQ | 3851 | P20929 | |
| DVIQAKKAYELQSDN | 4096 | P20929 |